Despite this, using imaging techniques and other auxiliary methods to detect changes in Vmat2 density and distribution in human brain regions (Singh et al., 2024) could provide new insights for the clinical diagnosis and treatment of depression. This evidence concerns the gene SLC18A2 and major depressive disorder.